CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Hepatology. 2017 Apr;65(4):1293-1305. doi: 10.1002/hep.28992. Epub 2017 Mar 6.
Obesity increases the risk of clinical decompensation in cirrhosis, possibly by increasing portal pressure. Whether weight reduction can be safely achieved through lifestyle (LS) changes (diet and exercise) in overweight/obese patients with cirrhosis, and if weight loss reduces portal pressure in this setting, is unknown. This prospective, multicentric, uncontrolled pilot study enrolled patients with compensated cirrhosis, portal hypertension (hepatic venous pressure gradient [HVPG] ≥6 mm Hg), and body mass index (BMI) ≥26 kg/m in an intensive 16-week LS intervention program (personalized hypocaloric normoproteic diet and 60 min/wk of supervised physical activity). We measured HVPG, body weight (BW) and composition, adipokines, health-related quality of life, and safety data before and after the intervention. Changes in HVPG and BW were predefined as clinically relevant if ≥10% and ≥5%, respectively. Safety and BW were reassessed after 6 months. 60 patients were included and 50 completed the study (56 ± 8 years old; 62% male; nonalcoholic steatohepatitis etiology 24%; BMI 33.3 ± 3.2 kg/m ; Child A 92%; HVPG ≥10 mm Hg, 72%). LS intervention significantly decreased BW (average, -5.0 ± 4.0 kg; P < 0.0001), by ≥5% in 52% and ≥10% in 16%. HVPG also significantly decreased (from 13.9 ± 5.6 to 12.3 ± 5.2 mm Hg; P < 0.0001), by ≥10% in 42% and ≥20% in 24%. A ≥10% BW loss was associated with a greater decrease in HVPG (-23.7 ± 19.9% vs. -8.2 ± 16.6%; P = 0.024). No episodes of clinical decompensation occurred. Weight loss achieved at 16 weeks was maintained at 6 months; Child and Model for End-Stage Liver Disease scores did not change.
Sixteen weeks of diet and moderate exercise were safe and reduced BW and portal pressure in overweight/obese patients with cirrhosis and portal hypertension. (Hepatology 2017;65:1293-1305).
探讨超重/肥胖的代偿性肝硬化患者通过生活方式(饮食和运动)改变是否能安全地减轻体重,以及在这种情况下体重减轻是否能降低门静脉压力。
这项前瞻性、多中心、非对照的初步研究纳入了在强化 16 周生活方式干预方案(个性化低热量正常蛋白饮食和 60 分钟/周的监督体育活动)中患有代偿性肝硬化、门静脉高压(肝静脉压力梯度[HVPG]≥6mmHg)和体质指数(BMI)≥26kg/m²的患者。我们在干预前后测量了 HVPG、体重(BW)和成分、脂肪因子、健康相关生活质量和安全性数据。如果 HVPG 和 BW 的变化分别≥10%和≥5%,则认为具有临床意义。安全性和 BW 在 6 个月后重新评估。
共纳入 60 例患者,其中 50 例完成了研究(56±8 岁;62%为男性;非酒精性脂肪性肝炎病因 24%;BMI 33.3±3.2kg/m²;Child A 92%;HVPG≥10mmHg,72%)。生活方式干预显著降低了 BW(平均,-5.0±4.0kg;P<0.0001),≥5%的患者占 52%,≥10%的患者占 16%。HVPG 也显著降低(从 13.9±5.6mmHg 降至 12.3±5.2mmHg;P<0.0001),≥10%的患者占 42%,≥20%的患者占 24%。BW 减少≥10%与 HVPG 降低更显著相关(-23.7±19.9%比-8.2±16.6%;P=0.024)。无临床失代偿事件发生。16 周时的体重减轻在 6 个月时得到维持;Child 和终末期肝病模型评分无变化。
16 周的饮食和适度运动是安全的,可以降低超重/肥胖的代偿性肝硬化伴门静脉高压患者的 BW 和门静脉压力。